Ozone (O<sub>2</sub> - O<sub>3</sub>) Has SYSADOA (Symptomatic Slow Acting Drug for Osteoarthritis) and DMDOA (Disease Modifying Drug for Osteoarthritis) Effect in Knee Osteoarthritis Patients
| Author | Marcos Edgar Fernandez-Cuadros | en |
| Author | Maria Jesus Albaladejo-Florin | en |
| Author | Olga Susana Perez-Moro | en |
| Author | Sandra Alava-Rabasa | en |
| Orcid | Marcos Edgar Fernandez-Cuadros [0000-0001-6153-9075] | en |
| Orcid | Maria Jesus Albaladejo-Florin [0000-0002-4561-8037] | en |
| Orcid | Olga Susana Perez-Moro [0000-0002-6218-4381] | en |
| Orcid | Sandra Alava-Rabasa [0000-0003-3199-4194] | en |
| Issued Date | 2019-07-31 | en |
| Abstract | This article does not have an abstract. | en |
| DOI | https://doi.org/10.5812/mejrh.90513 | en |
| Keyword | Ozone Therapy | en |
| Keyword | Knee Osteoarthritis | en |
| Keyword | Biomarkers | en |
| Keyword | Pain | en |
| Keyword | Quality of Life | en |
| Keyword | Function | en |
| Publisher | Brieflands | en |
| Title | Ozone (O<sub>2</sub> - O<sub>3</sub>) Has SYSADOA (Symptomatic Slow Acting Drug for Osteoarthritis) and DMDOA (Disease Modifying Drug for Osteoarthritis) Effect in Knee Osteoarthritis Patients | en |
| Type | Discussion | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- mejrh-6-3-90513.pdf
- Size:
- 79.9 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF